The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

• Published in: Leukemia Vol. 34; no. 10; pp. 2790 - 2793
• Main Authors: Lai, Peilong, Chen, Xiaomei, Qin, Le, Jiang, Zhiwu, Luo, Chenwei, Huang, Xin, Wu, Sujing, Ling, Wei, Wang, Yulian, Wang, Jinghua, Deng, Chenxin, Huang, Lisi, Zeng, Lingji, Lu, Zesheng, Zhong, Liye, Liao, Pengjun, Li, Minming, Chen, Dongmei, Geng, Suxia, Wu, Ping, Tang, Zhaoyang, Pei, Duanqing, Du, Xin, Li, Peng, Weng, Jianyu
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.10.2020; Nature Publishing Group
• Subjects: 14/5; 631/250/251; 64/60; 692/700/565/251; Animals; Cancer Research; Cell therapy; Critical Care Medicine; Development and progression; Disease Models, Animal; Female; Health aspects; Hematology; Hepatitis B; Hepatitis B - complications; Hepatitis B - diagnosis; Hepatitis B - immunology; Hepatitis B - virology; Hepatitis B virus - immunology; Humans; Immunotherapy, Adoptive - adverse effects; Immunotherapy, Adoptive - methods; Intensive; Internal Medicine; Letter; Lymphocytes; Lymphocytes T; Male; Medicine; Medicine & Public Health; Mice; Middle Aged; Oncology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; T cells; T-Lymphocytes - immunology; T-Lymphocytes - metabolism; Treatment Outcome; Xenograft Model Antitumor Assays